Condition
Pain Detection
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06972212Early Phase 1CompletedPrimary
Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
NCT06600607Early Phase 1CompletedPrimary
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
NCT00447824Not ApplicableUnknownPrimary
Pain Detection and Interception in Neonates
Showing all 3 trials